Hormonal risk factors and invasive epithelial ovarian cancer risk by parity

British Journal of Cancer

Volumn 109, Issue 3, 2013, Pages 769-776

  Bodelon, C ^a   Wentzensen, N ^a   Schonfeld, S J ^a,b   Visvanathan, K ^c,d   Hartge, P ^a   Park, Y ^a   Pfeiffer, R M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE;

ADULT; AGED; ARTICLE; BODY MASS; CANCER HORMONE THERAPY; CANCER RISK; CANCER SCREENING; FEMALE; GENETIC HETEROGENEITY; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; NULLIPARA; OVARY CANCER; PARITY; PRIORITY JOURNAL; RISK FACTOR; TUMOR INVASION;

AGED; COHORT STUDIES; FEMALE; HUMANS; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PARITY; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; UNITED STATES;

EID: 84883199350     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.344     Document Type: Article

References (22)

1. Adami HO, Hsieh CC, Lambe M, Trichopoulos D, Leon D, Persson I, Ekbom A, Janson PO (1994) Parity, age at first childbirth, and risk of ovarian cancer. Lancet 344(8932): 1250-1254.
2. Collaborative Group on Epidemiological Studies of Ovarian Cancer (2012) Ovarian cancer and body size: individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies. PLoS Med 9(4): e1001200.
3. Collaborative Group on Epidemiological Studies of Ovarian CancerBeral V, Gaitskell K, Hermon C, Moser K, Reeves G, Peto R (2012) Ovarian cancer and smoking: individual participant meta-analysis including 28,114 women with ovarian cancer from 51 epidemiological studies. Lancet Oncol 13(9): 946-956.
4. Cramer DW, Xu H, Harlow BL (1995) Does 'incessant' ovulation increase risk for early menopause? Am J Obstet Gynecol 172(2, Part 1): 568-573.
5. Fritz AG, Percy C, Jack A, Shanmugarathan K, Sobin L, Parkin DM, Whelan S (2000) International Classification of Diseases for Oncology, ICD-O. World Health Organization: Geneva, Switzerland.
6. George N (2011) Determinants of lifetime ovulatory cycles and risk of ovarian cancer. Masters of Public Health Masters of Public Health, The George Washington University.
7. Grambsch PM, Therneau TM (1994) Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81(3): 515-526.
8. Greer JB, Modugno F, Ness RB, Allen GO (2006) Anthropometry and the risk of epithelial ovarian cancer. Cancer 106(10): 2247-2257.
9. Hankinson SE, Danforth KN (2006) Ovarian cancer. In Cancer Epidemiology and Prevention, Schottenfeld D, Fraumeni Jr JF (eds) 3 edn. Oxford University Press, Inc.: New York, NY, USA.
10. Leitzmann MF, Koebnick C, Danforth KN, Brinton LA, Moore SC, Hollenbeck AR, Schatzkin A, Lacey Jr JV (2009) Body mass index and risk of ovarian cancer. Cancer 115(4): 812-822.
11. Michaud D, Midthune D, Hermansen S, Leitzmann M, Harlan LC, Kipnis V, Schatzkin A (2005) Comparison of cancer registry case ascertainment with SEER estimates and self-reporting in a subset of the NIH-AARP Diet and Health Study. J Registry Manage 32(2): 70-75.
12. Modugno F, Ness RB, Wheeler JE (2001) Reproductive risk factors for epithelial ovarian cancer according to histologic type and invasiveness. Ann Epidemiol 11(8): 568-574.
13. Moorman PG, Calingaert B, Palmieri RT, Iversen ES, Bentley RC, Halabi S, Berchuck A, Schildkraut JM (2008) Hormonal risk factors for ovarian cancer in premenopausal and postmenopausal women. Am J Epidemiol 167(9): 1059-1069.
14. Ness RB, Ann Grisso J, Klapper J, Schlesselman JJ, Silberzweig S, Vergona R, Morgan M, Wheeler JE. and the SHARE Study Group (2000) Risk of ovarian cancer in relation to estrogen and progestin dose and use characteristics of oral contraceptives. Am J Epidemiol 152(3): 233-241.
15. Ness RB, Grisso JA, Vergona R, Klapper J, Morgan M, Wheeler JE (2001) Oral contraceptives, other methods of contraception, and risk reduction for ovarian cancer. Epidemiology 12(3): 307-312.
16. Olsen CM, Nagle C, Whiteman DC, Ness R, Pearce CL, Pike MC, Rossing MA, Terry K, Wu A, Risch H, Yu H, Doherty JA, Chang-Claude J, Hein R, Nickels S, Wang-Gohrke S, Goodman M, Carney ME, Matsuno RK, Lurie G, Moysich K, Kjaer SK, Jensen A, Hogdall E, Goode E, Fridley BL, Vierkant RA, Larson MC, Schildkraut J, Hoyo C, Moorman P, Weber RP, Cramer D, Vitonis AF, Bandera EV, Olsen S, Rodriguez-Rodriguez L, King M, Brinton LA, Yang H, Garcia-Closas M, Lissowska J, Anton-Culver H, Ziogas A, Gayther SA, Ramus SJ, Menon U, Gentry-Maharaj A, Webb PM (2013) Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium. Endocr Relat Cancer 20(2): 251-262.
17. Prorok PC, Andriole GL, Bresalier RS, Buys SS, Chia D, Crawford ED, Fogel R, Gelmann EP, Gilbert F, Hasson MA, Hayes RB, Johnson CC, Mandel JS, Oberman A, O'Brien B, Oken MM, Rafla S, Reding D, Rutt W, Weissfeld JL, Yokochi L, Gohagan JK (2000) Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Controll Clin Trial 21(6 Suppl): 273S-309S.
18. Schatzkin A, Subar AF, Thompson FE, Harlan LC, Tangrea J, Hollenbeck AR, Hurwitz PE, Coyle L, Schussler N, Michaud DS, Freedman LS, Brown CC, Midthune D, Kipnis V (2001) Design and serendipity in establishing a large cohort with wide dietary intake distributions: the National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am J Epidemiol 154(12): 1119-1125.
19. Schonfeld SJ, Pfeiffer RM, Lacey JV, Berrington de González A, Doody MM, Greenlee RT, Park Y, Schairer C, Schatzkin A, Sigurdson AJ, Hartge P, Visvanathan K (2011) Hormone-related risk factors and postmenopausal breast cancer among nulliparous versus parous women: an aggregated study. Am J Epidemiol 173(5): 509-517.
20. Tung K-H, Wilkens LR, Wu AH, McDuffie K, Nomura AMY, Kolonel LN, Terada KY, Goodman MT (2005) Effect of anovulation factors on pre-and postmenopausal ovarian cancer risk: revisiting the incessant ovulation hypothesis. Am J Epidemiol 161(4): 321-329.
21. Vachon CM, Mink PJ, Janney CA, Sellers TA, Cerhan JR, Hartmann L, Folsom AR (2002) Association of parity and ovarian cancer risk by family history of breast or ovarian cancer in a population-based study of postmenopausal women. Epidemiology 13(1): 66-71.
22. Whittemore AS, Harris R, Itnyre J (1992) Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol 136(10): 1184-1203.